5 key recommendations to improve prevention, treatment & care of Chronic Kidney Disease (CKD) in the aftermath of COVID-19
Chronic Kidney Disease (CKD) is a serious condition where the kidneys are damaged and cannot filter blood properly. Kidney disease has...
EKPF present the Vascular Accesses Handbbook
Vascular Access is a key for the life of People with Kidney chronis diasease in haemodialysis treatment, For this reason EKPF decided to...
EKHA has contributed to a new article published on CJASN
Raymond Vanholder (European Kidney Health Aalliance, EKHA´s President) is the co-author of a new article titled “Health Policy for...
New results on SGLT2 inhibitors slow disease progression
In large cardiovascular (CV) outcome trials of patients with type 2 diabetes (T2D), sodium–glucose co-transporter 2 (SGLT2) inhibitors...
SONG-CKD Have your say on what impacts of chronic kidney disease and treatment matter to you
You are invited to participate in a new Delphi Survey to understand what outcomes are important to patients, caregivers, family members...
EKHA General Assembly March 2020
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc nec ligula ullamcorper, blandit nunc at, pharetra nisi.
Congress of the European Patients Forum. November 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc nec ligula ullamcorper, blandit nunc at, pharetra nisi.
European Summit on Anti-Infective Therapies. October 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc nec ligula ullamcorper, blandit nunc at, pharetra nisi.
EPF's Statement on COVID-19 Pandemic
[fusion_builder_container background_parallax="none" enable_mobile="no" parallax_speed="0.3" background_repeat="no-repeat"...
Sustainable trade tactics
[fusion_builder_container background_parallax="none" enable_mobile="no" parallax_speed="0.3" background_repeat="no-repeat"...
ESOT Patients Meeting September 2019
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc nec ligula ullamcorper, blandit nunc at, pharetra nisi.